1) ESS/W...majority non-dilutive grants...avaaila
Post# of 30028
2) affirmation of 2diablos....development..and exit (except MANF for now
3) near term ...early 15 exit of lympro from incubator
4) increased intrinsic value to be realized by Q1 15
mosserman